We are live on
!
Find out more
CAD
Craig A. Drill Portfolio holdings
AUM
$24.4M
1-Year Est. Return
13.42%
This Fund
S&P 500
This Quarter
Est. Return
+10.5%
1 Year Est. Return
+13.42%
3 Year Est. Return
+67.09%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.7M
AUM Growth
+$11.1M
(+28%)
Cap. Flow
+$9.01M
Cap. Flow
% of AUM
17.77%
Top 10 Holdings %
Top 10 Hldgs %
95.69%
Holding
19
New
4
Increased
3
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYNO
Cynosure, Inc. Class A
CYNO
|
+$17.3M |
| 2 |
EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
|
+$1.33M |
| 3 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$1.16M |
| 4 |
ARLZ
Aralez Pharmaceuticals Inc.
ARLZ
|
+$926K |
| 5 |
ELOS
Syneron Medical Ltd
ELOS
|
+$834K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIEN
Sientra, Inc.
SIEN
|
+$3.58M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$3.37M |
| 3 |
LBY
Libbey, Inc.
LBY
|
+$2.46M |
| 4 |
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
|
+$1.56M |
| 5 |
CUTR
Cutera, Inc.
CUTR
|
+$843K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 72.65% |
| 2 | Consumer Discretionary | 16.32% |
| 3 | Consumer Staples | 6.76% |
| 4 | Industrials | 2.03% |
| 5 | Technology | 1.8% |
Similar funds
GPI
SIG
EDRPMB
GMIM
DMS
DPA
PA
IC
Craig A. Drill's Q2 2016 Portfolio in Review
As of Q2 2016, Craig A. Drill held 19 positions worth $50.7M, up 28% from $39.7M the previous quarter. Its ten largest holdings account for 96% of the portfolio.
Craig A. Drill deployed $9.01M of net new capital in Q2 2016, opening 4 new positions and adding to 3 existing holdings. Its largest new stake was Cynosure, Inc. Class A: 364,300 shares worth $17.7M.
By sector, the portfolio is most concentrated in Healthcare at 73% of assets, up from 56% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.
On the sell side, the largest reduction was BioTelemetry, Inc., an estimated $3.37M trimmed.
- Craig A. Drill's largest Q2 2016 buy was Cynosure, Inc. Class A: 364,300 shares worth $17.7M.
- Craig A. Drill added most to Aralez Pharmaceuticals Inc. in Q2 2016, an estimated $926K increase.
- Craig A. Drill's biggest Q2 2016 reduction was BioTelemetry, Inc., cutting an estimated $3.37M.
- Craig A. Drill fully exited Sientra, Inc. in Q2 2016, selling an estimated $3.58M.
- Craig A. Drill's ten largest holdings make up 96% of its $50.7M portfolio in Q2 2016.
- Craig A. Drill opened 4 new positions and closed 4 in Q2 2016.
- Craig A. Drill's portfolio value rose 28% quarter-over-quarter to $50.7M.
Based on Craig A. Drill's 13F filing for Q2 2016, filed 4 Aug 2016.